Diabetes complications

A Metabolomics Study of Cardiac Dysfunction in Hyperglycemia: Findings From the Atherosclerosis Risk in Communities (ARIC) Study and the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

Diabetes CarePublished Metabolomics study with cross-sectional and prospective analyses of the ARIC cohort, replicated in HCHS/SOL

Authors' conclusion

Metabolites known for microvascular complications were associated with cardiac dysfunction in hyperglycemic individuals but not among their euglycemic counterparts, supporting the premise that microvascular dysfunction contributes to HF pathogenesis in diabetes.

Study context

Population
Heart failure (HF)-free participants of ARIC visit 5, 2011–2013; replication in HCHS/SOLARIC visit 5 · replication in HCHS/SOL 5,167
Participants
2,492 participants
Exposure
Metabolites associated with cardiac dysfunction in hyperglycemic vs euglycemic individuals
  • Hyperglycemicn = 1,297
  • Euglycemicn = 1,195
Outcome
Subclinical cardiac dysfunction (echocardiographic abnormalities: LV hypertrophy, systolic or diastolic dysfunction; or elevated NT-proBNP or troponin T) associated with 790 metabolites
Methodological detailsreplication cohort (HCHS/SOL)
  • Replication cohort (HCHS/SOL)

Main finding

As reported in the abstract

Metabolites associated with cardiac dysfunction
  • Hyperglycemic: microvascular disease-related metabolites (e.g., pseudouridine, N6-carbamoylthreonyladenosine, N6-acetyllysine, N2,N5-diacetylornithine) associated with cardiac dysfunction
  • Euglycemic: carbohydrate and cofactor-derived metabolites (e.g., gulonate, erythrocyte) associated with cardiac dysfunction

Observational data: associations, not effects.

Further findings

Prospective association of cardiac dysfunction-related metabolites with HF risk · follow-up 7.5 years

Cardiac dysfunction-related metabolites were prospectively associated with HF risk in the two glycemic groups
  • Cox regression adjusted for clinical risk factors

Replication in HCHS/SOL

HCHS/SOL results were consistent with those from ARIC

Original publication

A Metabolomics Study of Cardiac Dysfunction in Hyperglycemia: Findings From the Atherosclerosis Risk in Communities (ARIC) Study and the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Diabetes Care. Published 29 July 2025. doi:10.2337/dc25-0730

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.